Group I (EMLA) received EMLA cream, whereas Group II (Myolaxin) received Myolaxin ointment. For both groups the cream was applied at the venous cannulation site (dorsum of the non-dominant hand ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback